1. AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation
- Author
-
Jian Xiong Feng, Zexian Liu, Dan Xie, Chao Zhang, Jia Jia Hu, Gong Chen, Huai-Qiang Ju, Yun Xin Lu, Marcia A. Ogasawara, Ying qin Li, Yang Chen, Ying Nan Wang, Qi Zhao, Jin Ping Yun, Zhizhong Pan, Hui Chang Bi, Feng Tian, Kai Yan Liu, Ying Jin, Zhao Lei Zeng, Song Gao, Yi Ming Jiang, Scott Kopetz, Feng Wang, Jie Liu, Rui-Hua Xu, Wei Hua Jia, and Hui Sheng
- Subjects
Male ,Threonine ,0301 basic medicine ,Cancer Research ,Carcinogenesis ,Colorectal cancer ,Glutathione reductase ,Apoptosis ,Kaplan-Meier Estimate ,AMP-Activated Protein Kinases ,medicine.disease_cause ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Antineoplastic Combined Chemotherapy Protocols ,Phosphorylation ,RNA, Small Interfering ,Drug Synergism ,Middle Aged ,Cancer metabolism ,Oxaliplatin ,Survival Rate ,Glutathione Reductase ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,Female ,Colorectal Neoplasms ,Oxidation-Reduction ,medicine.drug ,Cell Survival ,Biology ,Article ,03 medical and health sciences ,Stress, Physiological ,Cell Line, Tumor ,Genetics ,medicine ,Animals ,Humans ,Molecular Biology ,Survival rate ,Aged ,Neoplasm Staging ,Glutathione ,medicine.disease ,Xenograft Model Antitumor Assays ,030104 developmental biology ,chemistry ,Cancer research ,Reactive Oxygen Species ,Homeostasis - Abstract
Patients with stage II or III colorectal cancer (CRC) exhibit various clinical outcomes after radical treatments. The 5-year survival rate was between 50 and 87%. However, the underlying mechanisms of the variation remain unclear. Here we show that AMPKα1 is overexpressed in CRC patient specimens and the high expression is correlated with poor patient survival. We further reveal a previously unrecognized function of AMPKα1, which maintains high level of reduced glutathione to keep reduction–oxidation reaction (redox) homeostasis under stress conditions, thus promoting CRC cell survival under metabolic stress in vitro and enhancing tumorigenesis in vivo. Mechanistically, AMPKα1 regulate the glutathione reductase (GSR) phosphorylation possibly through residue Thr507 which enhances its activity. Suppression of AMPKα1 by using nano-sized polymeric vector induces a favorable therapeutic effect, especially when in combination with oxaliplatin. Our study uncovers a novel function of AMPKα1 in redox regulation and identifies a promising therapeutic strategy for treatment of CRC.
- Published
- 2019
- Full Text
- View/download PDF